BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16014416)

  • 1. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
    Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis.
    Lolli F; Mazzanti B; Pazzagli M; Peroni E; Alcaro MC; Sabatino G; Lanzillo R; Brescia Morra V; Santoro L; Gasperini C; Galgani S; D'Elios MM; Zipoli V; Sotgiu S; Pugliatti M; Rovero P; Chelli M; Papini AM
    J Neuroimmunol; 2005 Oct; 167(1-2):131-7. PubMed ID: 16051375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designed glycopeptides with different beta-turn types as synthetic probes for the detection of autoantibodies as biomarkers of multiple sclerosis.
    Carotenuto A; Alcaro MC; Saviello MR; Peroni E; Nuti F; Papini AM; Novellino E; Rovero P
    J Med Chem; 2008 Sep; 51(17):5304-9. PubMed ID: 18712857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
    Carotenuto A; D'Ursi AM; Mulinacci B; Paolini I; Lolli F; Papini AM; Novellino E; Rovero P
    J Med Chem; 2006 Aug; 49(17):5072-9. PubMed ID: 16913697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The glycan role in the glycopeptide immunogenicity revealed by atomistic simulations and spectroscopic experiments on the multiple sclerosis biomarker CSF114(Glc).
    Bruno A; Scrima M; Novellino E; D'Errico G; D'Ursi AM; Limongelli V
    Sci Rep; 2015 Mar; 5():9200. PubMed ID: 25776265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferrocenyl glycopeptides as electrochemical probes to detect autoantibodies in multiple sclerosis patients' sera.
    Real-Fernández F; Colson A; Bayardon J; Nuti F; Peroni E; Meunier-Prest R; Lolli F; Chelli M; Darcel C; Jugé S; Papini AM
    Biopolymers; 2008; 90(4):488-95. PubMed ID: 18273890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.
    Schwarz M; Spector L; Gortler M; Weisshaus O; Glass-Marmor L; Karni A; Dotan N; Miller A
    J Neurol Sci; 2006 May; 244(1-2):59-68. PubMed ID: 16480743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designed glucopeptides mimetics of myelin protein epitopes as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
    Pandey S; Alcaro MC; Scrima M; Peroni E; Paolini I; Di Marino S; Barbetti F; Carotenuto A; Novellino E; Papini AM; D'Ursi AM; Rovero P
    J Med Chem; 2012 Dec; 55(23):10437-47. PubMed ID: 23167575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody recognition in multiple sclerosis and Rett syndrome using a collection of linear and cyclic N-glucosylated antigenic probes.
    Real Fernández F; Di Pisa M; Rossi G; Auberger N; Lequin O; Larregola M; Benchohra A; Mansuy C; Chassaing G; Lolli F; Hayek J; Lavielle S; Rovero P; Mallet JM; Papini AM
    Biopolymers; 2015 Sep; 104(5):560-76. PubMed ID: 25973844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fmoc-protected iminosugar modified asparagine derivatives as building blocks for glycomimetics-containing peptides.
    Nuti F; Paolini I; Cardona F; Chelli M; Lolli F; Brandi A; Goti A; Rovero P; Papini AM
    Bioorg Med Chem; 2007 Jun; 15(12):3965-73. PubMed ID: 17459712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis.
    Beyer NH; Milthers J; Bonde Lauridsen AM; Houen G; Lautrup Frederiksen J
    Scand J Clin Lab Invest; 2007; 67(7):696-706. PubMed ID: 17852796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
    Niccheri F; Real-Fernàndez F; Ramazzotti M; Lolli F; Rossi G; Rovero P; Degl'Innocenti D
    J Mol Recognit; 2014 Oct; 27(10):618-26. PubMed ID: 25178857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslationally modified peptides efficiently mimicking neoantigens: a challenge for theragnostics of autoimmune diseases.
    Nuti F; Peroni E; Real-Fernández F; Bonache MA; Le Chevalier-Isaad A; Chelli M; Lubin-Germain N; Uziel J; Rovero P; Lolli F; Papini AM
    Biopolymers; 2010; 94(6):791-9. PubMed ID: 20564034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
    Real-Fernández F; Passalacqua I; Peroni E; Chelli M; Lolli F; Papini AM; Rovero P
    Sensors (Basel); 2012; 12(5):5596-607. PubMed ID: 22778603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational landscape of N-glycosylated peptides detecting autoantibodies in multiple sclerosis, revealed by Hamiltonian replica exchange.
    Guardiani C; Signorini GF; Livi R; Papini AM; Procacci P
    J Phys Chem B; 2012 May; 116(18):5458-67. PubMed ID: 22519978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
    Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
    J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
    Pandey S; Dioni I; Lambardi D; Real-Fernandez F; Peroni E; Pacini G; Lolli F; Seraglia R; Papini AM; Rovero P
    Mol Cell Proteomics; 2013 Feb; 12(2):277-82. PubMed ID: 23139387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction Study of Phospholipid Membranes with an N-Glucosylated β-Turn Peptide Structure Detecting Autoantibodies Biomarkers of Multiple Sclerosis.
    Becucci L; Benci S; Nuti F; Real-Fernandez F; Vaezi Z; Stella L; Venanzi M; Rovero P; Papini AM
    Membranes (Basel); 2015 Sep; 5(4):576-96. PubMed ID: 26437433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplexing approaches for autoantibody profiling in multiple sclerosis.
    Somers K; Govarts C; Stinissen P; Somers V
    Autoimmun Rev; 2009 Jun; 8(7):573-9. PubMed ID: 19393211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
    Garg N; Zivadinov R; Ramanathan M; Vasiliu I; Locke J; Watts K; Lema J; Rajeswary J; Munschauer FE; Ambrus J; Weinstock-Guttman B
    J Neuroimmunol; 2007 Jul; 187(1-2):159-65. PubMed ID: 17512610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.